Articles by Control, a senior compliance officer - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Control, a senior compliance officer

Holding Back

If not properly monitored, filters and plastic bags can keep back more than they should.
Mar 2, 2008

If not properly monitored, filters and plastic bags can keep back more than they should.

AIM-less

If at first the product fails, then inspect, inspect again
Feb 2, 2008

If at first the product fails, then inspect, inspect again

Trash and Treasures

Process efficiency is measured not only by what is kept, but also by what is thrown away.
Jan 2, 2008

Process efficiency is measured not only by what is kept, but also by what is thrown away.

Why We Do What We Do

The "why" things are done in this industry is just as important as the "what"and "how."
Dec 2, 2007

The "why" things are done in this industry is just as important as the "what"and "how."

Agent in Place: Statistically Unstable

Thin are the lines that separate stability, statistics, and chaos.
Nov 2, 2007

Thin are the lines that separate stability, statistics, and chaos.

Agent in Place: Vials and Villains

Our files pull up lost contracts, poor competitive tactics, and an over-ambitious employee.
Oct 2, 2007

Our files pull up lost contracts, poor competitive tactics, and an over-ambitious employee.

Self-destruction

Poor processing and misguided projections lead to trashed product.
Sep 2, 2007

Poor processing and misguided projections lead to trashed product.

Supplier Woes

Production sometimes follows the law of supply and reprimand.
Aug 2, 2007

Production sometimes follows the law of supply and reprimand.

What Once Was

The good ol' days weren't always good.
Jul 2, 2007

The good ol' days weren't always good.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
FindPharma Custom Search
Click here